Pear Therapeutics, Inc. specializes in the creation and market introduction of software-driven medical therapies. The company boasts a growing portfolio of digital products and candidates, primarily addressing severe psychiatric and neurological conditions. Notable offerings include PearConnect, a dedicated support hub for users of its prescription digital therapeutics; reSET, designed to manage substance use disorder; reSET-O, specifically for opioid use disorder; and Somryst, an intervention for chronic insomnia.